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Background: In April 2014 we investigated the association of migration of a woman’s husband with her high-risk
human papillomavirus (HR-HPV) infection status and her abnormal cervical cytology status in the Achhamdistrict
of rural far-western Nepal.
Methods:Womenwere surveyed and screened for HR-HPVduring a health camp conducted by the Nepal Fertility
Care Center. Univariate and multivariable statistical tests were performed to determine the association of a
husband’s migration status with HR-HPV infection and cervical cytology status.
Results: In 265 women, the prevalence of HR-HPVwas 7.5% (20/265), while the prevalence of abnormal cervical
cytology, defined using the Bethesda system as atypical glandular cells of undetermined significance or worse,
was 7.6% (19/251). Half of the study participants (50.8%, 130/256) had husbands who had reported migrating
for work at least once. Women aged ≤34 years were significantly less likely to test positive for HR-HPV than
women aged >34 years (OR 0.22, 95% CI 0.07 to 0.71). HR-HPV infection and abnormal cervical cytology
status were not directly associated with a husband’s migration.
Conclusion:Older womenwere found to have a higher prevalence of HPV than younger women. It is possible that
a husband’s migration for work could be delaying HR-HPV infections in married women until an older age.
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Introduction
In 2012, 528 000 new cases of cervical cancer were diagnosed
and 266 000 women died of the disease, nearly 90% of them in
low- and middle-income countries (LMICs).1 Barriers to cervical
cancer screening, such as access to health care, low levels of
screening knowledge, and a lack of perceived benefits from
screening, impede early cervical cancer diagnosis in LMICs.2,3 In
Nepal, where routine cervical screening is not widely available,
cervical cancer is usually only detected when it is at an advanced
stage which results in high mortality.
Due to a current scarcity of cervical screening and treatment
programs, it is important to identify sub-populations of Nepali
women who are at a greater risk for cervical cancer. In addition
to risky sexual behaviors, social factors such as education,
wealth and marital status are associated with abnormal cervical
cytology outcomes.4–7 Due to lack of work during the agricultural
off-season, a large proportion of men migrate to urban areas
within Nepal, India or other countries for employment. Living
away from a spouse potentially makes migrant workers vulner-
able to STIs including high-risk human papillomavirus (HR-HPV)
through extra-marital sexual contacts. In this regard, returning
male migrants can also contribute to the risk of transmitting
HPV to their wives whomay subsequently develop cervical cancer.
Over 2.2 million Nepalese are engaged in international and
domestic labor migration; the Nepal Central Bureau of Statistics
estimates that over half of Nepali households in the Far-Western
development region of Nepal have at least one family member
who participates in some form of migratory work.8 This large
group of highly mobile Nepali migrant workers poses unique
health challenges for Nepal.9 Male Nepali migrant labor has
been associated with increased risk of STIs including HIV.10,11
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In far-western Nepal approximately 41% of patients with HIV are
seasonal migrant laborers.12 By analogy, it is therefore possible
that male migrant work in Nepal could be a factor contributing
to cervical cancer among Nepali women.
To date, studies of factors associated with HPV infection and
cervical cancer morbidity in Nepal have been limited primarily to
urban populations with only one study performed in rural Nepal,
where labor migration is more common.2,13 The aim of this
study therefore is to investigate the association between hus-
bands’ migration for employment, and HR-HPV infection and
abnormal cervical cytology among their spouses, in the rural
Materials and methods
Study setting
This cross-sectional study was conducted within Sanfebagar
Village Development Committee, a local Nepali governmental
administrative division, in Achham District. The population of
Achham has poor indicators of health compared to the general
Nepali population. The life expectancy for both men and women
in Achham during 2011 was 55 years and the maternal mortality
ratewas 950 per 100 000 live births, both of which are worse than
the national life expectancy of 67 years, with amaternalmortality
rate of 170 per 100 000 live births.14 Currently, there are only two
hospitals in Achham; the government’s hospital in the district
capital of Mangalsen, and Bayalpata Hospital, a collaboration
between the Nepali government and the non-profit organization
Possible Health (formerly Nyaya Health).
Study population
Women were recruited from a Nepal Fertility Care Center
reproductive health (RH) camp.15 The RH camp was advertised
through local newspapers and female support groups two weeks
prior to conducting the camp.Womenwho attended the RH camp
received a wide array of free reproductive health services, includ-
ing testing for STIs, family planning counseling, and liquid
cytology testing. Women were eligible for the study if they were
married, between the ages of 16 and 60, had a cervix, were not
menstruating, and were not pregnant. Consent forms were dis-
tributed and read to each participant before they agreed to
enroll in the study. Each form was signed and dated by the study
participant, a witness, and the study coordinator. Any woman
who opted not to participate in the research study was provided
with the same clinical services during the RH camp as those
participating in the research study. Trained health staff with
several years of clinical experience performed pelvic examinations.
Institutional review boards from the University of Alabama at
Birmingham and the Nepal Health Research Council approved
this study.
Laboratory analysis
Study protocols on sample collection and testing have been
described previously.13 Briefly, health camp auxiliary nurse mid-
wives collected cervical specimens using ThinPrep PreservCyt
medium (Hologic/Gen-Probe Inc. San Diego, CA, USA). Cervical
specimens were transported to the Hologic/Gen-Probe Inc.
laboratory in San Diego for HPV testing. Laboratory testing of
HPV was performed using the APTIMA HPV assay (Hologic/
Gen-Probe Inc.), which detects the presence of mRNA from the
E6/E7 oncogenes for 14 types of HR-HPV (HPV 16, 18, 31, 33,
35, 39, 45, 51, 52, 56, 58, 59, 66, 68).16 Cervical cytology was
assessed for research purposes using clinician-collected samples
in ThinPrep PreservCyt medium (Hologic/Gen-Probe Inc.), with
results classified according to the Bethesda criteria.17 Women
with an abnormal cervical cytology were referred to local medical
centers for additional testing and follow-up.
Demographic and health risk survey
Women consenting to participate in the study completed a demo-
graphic and health risk survey, the details of which have been
described previously.13 Briefly, survey questions were translated
from English into Nepali, and then back-translated to English for
quality control. The local Nepali dialect called Dotyali is sometimes
spoken in the district of Achham and does not have a written form,
and thus the survey could not be translated into the local Achham
dialect.18,19 However, our interviewers were from Achham and
were able to speak both Nepali as well as Dotyali.
Independent and dependent variables
We analyzed two separate outcomes of interest: HR-HPV infection
(positive for at least one of the following types: HPV 16, 18, 31,
33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) and abnormal cervical
cytology classified according to the Bethesda criteria. Cervical
cytology was categorized as being either ‘Normal’ (benign cellular
changes, results within normal limits, atypical squamous cells of
undetermined significance [ASCUS], or actinomycosis) or ‘Abnor-
mal’ (atypical glandular cells of undetermined significance
[AGUS], or low-grade squamous intraepithelial lesion [LSIL], high-
grade SIL [HSIL], squamous cell carcinoma [SCC], or atypical squa-
mous cell-cannot exclude high-grade SIL [ASC-H]).
Demographic and socioeconomic variables included age,
average number of children per woman, if a husband had ever
migrated for work, if a migrating husband had returned home
within the last 3 months, and the geographic location visited by
a migrant husband. Age was categorized as being either ≤34
years or younger or >34 years in order to better represent the
average age of women whose husbands had migrated for work.
The geographic location of the husband’s migration was categor-
ized as ‘Migratedwithin Nepal for work’, ‘Migrated outside of Nepal
for work’, or ‘Has never migrated for work’. Additional variables
included STI awareness, cervical cancer awareness, and type of
current contraception use. Type of contraception currently used
was categorized in descriptive tables as hormonal, condom use,
other (defined as IUD and withdrawal) and none. In multivariate
models, type of contraception currently used was categorized as
hormonal, condom use/other, and none due to a small number of
women reporting condom use. Hormonal contraception was kept
as a separate category because past studies have reported an as-
sociation between abnormal cervical cytology and hormonal
contraception use.20,21 Hormonal contraception use included
the use of birth control pills, hormonal implants, and Depo-
Provera injections (Pfizer Inc, New York, NY, USA). Self-reported
health was categorized as ‘Excellent’, ‘Very Good’, ‘Good’, and
‘Fair/Poor’.
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Statistical analysis
All statistical analyses were limited to data frommarried women.
Cross-tabulationswere used to describe the frequencies of potential
risk factors associatedwith HR-HPV infection and the potential risk
factors associated with an abnormal cytology outcome.
ANOVA and statistical tests were used to determine the uni-
variate associations of continuous and categorical variables,
respectively, with HR-HPV and cervical cytology status.
Multivariable logistic regression models were used to generate
odds ratios and 95% CI describing factors associated with HR-HPV
infection. Based on 1. a review of HPV risk factor literature from
developing countries; 2. a p-value of less 0.1 in the univariate
analyses; or 3. if they were of primary interest for the study, final
models included the following covariates: age, cervical cancer
awareness, type of current contraception used, a husband’s
migratory status. Cervical cancer awareness was included in the
final models because it has been found to be associated with
abnormal Pap smears in previous studies.22 The type of contracep-
tion usedwas included in the finalmodels because it has been asso-
ciated with abnormal cervical cytology in previous studies.23,24
Multivariable logistic regressionmodels were also used to determine
odds ratios and 95% CI associated with an abnormal cervical cy-
tology.
Results
Out of 386 women who registered for the RH camp and met our
eligibility criteria of being married, being between the ages of 16
and 60, having a cervix, were not menstruating, and were not
pregnant, 363 women completed a demographic health survey.
Of these 363 women, 73.0% (265/363) had a HR-HPV test,
69.1% (251/363) hadavalid liquid-based cervical cytology reading
(Figure 1). Twenty women (7.5%, [20/265]) tested positive for
HR-HPV (Table 1) and 7.6% (19/251) of women had abnormal
liquid-based cervical cytology results (Table 2). The mean age of
study participants was 33.9 (SD 8.8) years. The percentage of
women who reported their health to be ‘Excellent’ was 26.2%
(69/263), 31.6% (83/263) of women reported their health to be
‘Very good’, 32.7% (86/263) of women reported their health to
be ‘Good’, and 9.5% (25/263) of women reported their health to
be ‘Fair/poor’ (Table 1).
Womenwhose husbands hadmigratedwithin Nepalwere signifi-
cantly younger thanbothwomenwhosehusbandsmigratedoutside
of Nepal for employment and women whose husbands had never
migrated for work (average age [SD]: ‘migrated within Nepal’, 28.8
[7.25], ‘migrated outside Nepal’, 33.7 [9.3], ‘never migrated’, 34.9
[8.5], p≤0.01). Unadjusted odds ratios assessing the association
between age and the migration status of a woman’s husband indi-
cated that women whose husbands migrated within Nepal for work
were over three times more likely to be aged 34 years or younger
than women whose husbands never migrated for work (unadjusted
OR [95% CI]: 3.68 [1.15 to 11.78]).
High risk HPV (HR-HPV)
HR-HPV infected women were more likely to have an abnormal
cervical cytology than women who were HR-HPV negative
(HR-HPV infected 60.0% [12/20] vs uninfected 3.1% [7/224])
(Table 1).
Multivariable logistic regression models using HR-HPV infection
as the outcome determined that women aged ≤34 years were
significantly less likely to be infected with HR-HPV than women
who were aged >34 years, after adjustment for current type of
contraception used, awareness of cervical cancer, and husband’s
migration status (OR 0.22, 95% CI 0.07 to 0.71, p=0.02) (Table 1).
A husband’s migratory status was not directly associated with
HR-HPV infection (‘migrated within Nepal’ OR 1.05, 95% CI 0.11
to 10.09; ‘migrated outside of Nepal’ OR 1.81, 95% CI 0.64 to
5.07; ‘never migrated’ was the reference group).
Cervical cytology
Sixty percent of women infected with HR-HPVwere categorized as
having an abnormal cervical cytology (12 women with either
AGUS, LSIL, ASC-H, HSIL or SCC / 20 women with HR-HPV), while
87.5% of women with squamous cell carcinoma or high-grade
SIL also tested positive for HR-HPV (7 women with HR-HPV and
HSIL or SCC / 8 women with HSIL or SCC) (Table 3). Multivariable
logistic regression models using abnormal cervical cytology
status as the outcome with normal cervical cytology as the refer-
ence category determined that women aged ≤34 years were less
likely to have an abnormal cervical cytology than women aged
>34 years (OR 0.31, 95% CI 0.11 to 0.93, p≤0.01), after adjusting
for current type of contraception used, awareness of cervical
Figure 1. Study design flow chart illustrating the selection procedure and
sample size of women attending a one-day reproductive health camp in
Achham, Nepal. HR-HPV: high-risk human papillomavirus.a Women were
eligible for the study if they were married, between the ages of 16 and
60, had a cervix, were not menstruating and were not pregnant.
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Table 1. Descriptive characteristics and multivariable logistic regression model assessing risk factors associated with high-risk human
papillomavirus (HR-HPV) infection in women attending a Nepal Fertility Care Center health camp in the Far-West region of Nepal
Variablesa Total number of
women who
have undergone
a HR-HPV test
HR-HPV
negative
HR-HPV
positive
p-valueb Adjusted OR (95%CI)c
n % n % n %
Age (n=262) 0.02
≤34 years 137 52.3 131 54.1 6 30.0 0.22 (0.07 to 0.71)
>34 years 125 47.7 111 45.9 14 70.0 Ref
Number of children (n=257) NS
0 9 3.5 8 3. 4 1 5.0
1–2 85 33.1 81 34.2 4 20.0
3–4 56 21.8 51 21.5 5 25.0
4+ 107 41.6 97 40.9 10 50.0
Cervical cytology (n=251) 0.001
Normal (WNL/BCC/ACTINO/ASCUS) 232 81.7 224 96.9 8 40.0
Abnormal (HSIL/SCC/ASC-H/AGUS/LSIL) 19 12.8 7 3.1 12 60.0
Self-reported health (n=263) NS
Excellent 69 26.2 64 26.3 5 25.0
Very good 83 31.6 74 30.5 9 45.0
Good 86 32.7 81 33.3 5 25.0
Fair/poor 25 9.5 24 9.8 1 5.0
Husband’s migration status (n=256) NS
Migrated within Nepal 20 7.8 19 8.0 1 5.3 1.05 (0.11 to 10.09)
Migrated outside of Nepal 110 42.9 100 42.2 10 52.6 1.81 (0.64 to 5.07)
Husband never migrated 126 49.2 118 49.8 8 42.1 Ref
Husband returned from working away from
home in the past 3 months (n=126)
NS
Yes 98 77.8 88 75.9 10 100.0
No 28 22.2 28 24.1 0 0
Awareness of cervical cancer (n=253) NS
Yes 20 7.9 131 56.2 11 55.0 1.15 (0.41 to 3.19)
No 233 92.1 102 43.8 9 45.0 Ref
Type of current contraception use (n=255)d,e NS
Hormonal 69 27.1 62 26.4 7 35.0 2.14 (0.65 to 7.12)
Condom use 66 25.9 62 26.4 4 20.0 1.07 (0.30 to 3.80)
Other 15 5.9 13 5.5 2 10.0
Does not use contraception 105 41.2 98 41.7 7 35.0 Ref
Awareness of STIs (n=255) NS
Yes 144 56.5 134 56.8 10 52.6
No 111 43.5 102 43.2 9 47.4
ACTINO: actinomycosis; AGUS: atypical glandular cells of undetermined significance; ASC-H: atypical squamous cell-cannot exclude HSIL;
ASCUS: atypical squamous cells of undetermined significance; BCC: benign cellular changes; HR-HPV: high-risk human papillomavirus;
HSIL: high-grade squamous intraepithelial lesion; LSIL: low-grade squamous intraepithelial lesion; Ref: reference group; SCC; squamous cell
carcinoma; WNL: within normal limits.
a The value for each variable may vary due to missing survey data.
b NS = not significant at alpha equal to 0.05. P-value >0.05.
c Models adjusted for: age, awareness of cervical cancer, type of current contraception use, husband’s migration status. Multivariable logistic
regression models were used to generate odds ratios and 95% confidence intervals (CI) describing factors associated with HR-HPV infection
based on 1. a review of HPV risk factor literature from developing countries; 2. a p-value of less than 0.1 in the univariate analyses; or 3. if
they were of primary interest for the study. Final models included the following covariates: age, cervical cancer awareness, type of current
contraception used, a husband’s migratory status.
d Hormonal contraception was defined as the use of birth control pills, hormonal implants, and Depo-Provera injections.
e The category ‘Other’ was collapsed with ‘Condom use’ in the multivariate analysis.
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Table 2. Descriptive characteristics and multivariable logistic regression model of cervical cytology in women attending a Nepal Fertility Care
Center health camp in the Far-West region of Nepal
Variablesa Total number of
women with a
liquid-based cytology
result available
Normal
(WNL/BCC/
ACTINO/
ASCUS)
Abnormal
(HSIL/SCC/
ASC-H/
AGUS/LSIL)
p-valueb Adjusted OR (95% CI)c
n % n % n %
Age (n=248) NS
≤34 years 132 53.2 125 54.6 7 36.8 0.31 (0.11 to 0.93)
>34 years 116 46.8 104 45.4 12 63.2 Ref
Number of children (n=244) NS
0 8 3.3 7 3.0 1 7.7
1–2 81 33.2 78 33.8 3 23.1
3–4 51 20.9 48 20.8 3 23.1
4+ 104 42.6 98 42.4 6 46.2
HR-HPV statusd (n=251) 0.001
Positive 20 7.9 8 3.4 12 63.2
Negative 231 92.0 224 96.6 7 36.8
Self-reported health (n=250) NS
Excellent 64 25.6 57 24.7 7 36.8
Very good 82 32.8 75 32.5 7 36.8
Good 83 33.2 80 34.6 3 15.8
Fair/poor 21 8.4 19 8.2 2 10.5
Husband’s migration status (n=243) NS
Migrated within Nepal 19 7.8 17 7.6 2 10.5 1.24 (0.22 to 6.99)
Migrated outside of Nepal 107 44.0 102 45.5 5 26.3 0.49 (0.16 to 1.53)
Husband never migrated 117 48.2 105 46.9 12 63.2 Ref
Husband returned from working away
from home in the past 3 months (n=122)
NS
Yes 94 77.1 88 75.9 6 100.0
No 28 22.9 28 24.1 0 0
Awareness of cervical cancer (n=243) NS
Yes 106 43.6 96 42.9 10 52.6 1.86 (0.67 to 5.24)
No 137 56.4 128 57.1 9 47.4 Ref
Type of current contraception use (n=242)e,f NS
Hormonal 66 27.3 57 25.6 9 47.4 3.55 (0.98 to 12.85)
Condom Use 14 5.8 13 5.8 1 5.3 1.47 (0.36 to 5.92)
Other 63 26.0 59 26.5 4 21.1
Does not use contraception 99 40.9 94 42.2 5 26.3 Ref
Awareness of STIs (n=251) NS
Yes 137 54.6 124 53.4 13 68.4
No 114 45.4 108 46.6 6 31.6
ACTINO: actinomycosis; AGUS: atypical glandular cells of undetermined significance; ASC-H: atypical squamous cell-cannot exclude HSIL;
ASCUS: atypical squamous cells of undetermined significance; BCC: benign cellular changes; HSIL: high-grade squamous intraepithelial lesion;
LSIL: low-grade squamous intraepithelial lesion; Ref: reference group; SCC: squamous cell carcinoma; WNL: within normal limits.
a The value for each variable may vary due to missing survey data.
b NS = not significant at alpha equal to 0.05. P-value >0.05.
c Models adjusted for: age, awareness of cervical cancer, type of current contraception use, husband’s migration status. Multivariable logistic
regression models were used to generate odds ratios and 95% confidence intervals (CI) describing factors associated with HR-HPV infection
based on 1. a review of HPV risk factor literature from developing countries; 2. a p-value of less than 0.1 in the univariate analyses; or 3. if
they were of primary interest for the study. Final models included the following covariates: age, cervical cancer awareness, type of current
contraception used, a husband’s migratory status.
d HR-HPV status determined using APTIMA HR-HPV mRNA Assay (Hologic/Gen-Probe, Inc. San Diego, CA, USA).
e Hormonal contraception was defined as the use of birth control pills, hormonal implants, and Depo-Provera injections.
f The category ‘Other’ was collapsed with ‘Condom use’ in the multivariate analysis.
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cancer, and husband’s migration status (Table 2). Abnormal cer-
vical cytologywas not directly associatedwith a husband’smigra-
tory status (‘migrated within Nepal’ OR 1.24, 95% CI 0.22 to 6.99;
‘migrated outside of Nepal’ OR 0.49, 95% CI 0.16 to 1.53; ‘never
migrated’ was the reference group).
Discussion
Younger age was found to be protective against HR-HPV infection
and against having an abnormal cervical cytology. Additionally,
women aged 34 years and younger were found to be significantly
more likely than older women to have a husbandwhomigrated. It
is possible that married Nepali women are less likely to contract
HPV when they are younger because their husbands are working
away fromhome for extendedperiods of timeduring their younger
years. Our study’s inverse associations between younger age and
HR-HPV infection contrasts with most reports that suggest
younger women are more likely to test positive for HR-HPV than
older women.25,26 Young women between the ages of 25 and
34 years had the highest prevalence of HPV of any age group in
a study of 2501 women living in Kolkata, India.25 Women in
younger age groups of the ATHENA study, a multi-center clinical
trial of over 46 000 women, had higher percentages of HPV
infection than women in older age groups.26 It is possible that
the results from our study could indicate that age related cofac-
tors, such as having a husband who has previously migrated for
employment, could potentially delay HPV transmission among
women.
HPV studies conducted in Indian provinces bordering Nepal have
study populations with characteristics similar to our study popula-
tion and show a similar prevalence of HPV infection to our
study.27,28 Although it is almost impossible to know the exact
numbers of Nepalese who migrate to India for work, due to the
open border polices between the two countries, the Indian
provinces borderingNepal are known to havehigh rates of employed
Nepali migrant workers.29,30 Since the characteristics of our study
sample are similar to the characteristics of HPV studies conducted
in North India and the most popular destination for migration in
our study sample was India, it is possible that women from our
study whose husbands have traveled to India for employment
have similar cervical cytology and HPV infection rates as women
from areas in India with a high prevalence of Nepali workers.
It is possible the results of our study are due to cohort effects
which were unable to be measured using our data. Political strife
originating fromNepal’s 10-year-long civil war caused an increase
in the number of labor migrants between 1996 and 2007.31 With
migratory work proving to be profitable for many Nepali citizens,
the increase in migration which began during the civil war period
has continued to this day. It is possible that older women who
were married before the civil war period had husbands who
were more financially secure during the war-period and therefore
did not have tomigrate for work. In contrast, it is possible younger
womenwhoweremarried either during or after the conflict might
be more likely to have husbands who migrated for work. This
phenomenon could help explain why women who were aged
≤34 years were less likely to test positive for HR-HPV than older
individuals.
Our study could potentially suffer a self-selection bias. While we
are interpreting the results of our study as suggesting that it is hus-
bands who are transmitting HPV to the women, this may not
always be the case. It is possible that women are forming sexual
relationships with other men while their husbands are away and
are choosing not to participate in our study because of social
stigma. This could explain why younger women, who are normally
at a greater risk for testing positive for HR-HPV than older women,
were less likely to test positive for HR-HPV in our study sample.
Our studywas a cross-sectional survey conducted in one area of
Achham district and it is possible our study did not adequately
Table 3. High-risk human papillomavirus (HR-HPV) test results and husband’s migration status stratified by liquid-based cytology
Liquid-based cytologya results of clinician-collected samples
SCC HSIL ASC-H LSIL AGUS ASCUS WNL/BCC/ACTINO Total
Total cytology results 1 7 6 4 1 27 205 251
HR-HPVb
Positive 1 6 2 3 0 2 6 20
Negative 0 1 4 1 1 25 199 231
Husband’s migration statusc
Migrated within Nepal 0 0 1 1 0 2 15 19
Migrated outside of Nepal 1 2 1 1 0 8 94 107
Never migrated for work 0 5 4 2 1 16 89 117
ACTINO: actinomycosis; AGUS: atypical glandular cells of undetermined significance; ASC-H: atypical squamous cell-cannot exclude HSIL;
ASCUS: atypical squamous cells of undetermined significance; BCC: benign cellular changes; HR-HPV: high-risk human papillomavirus;
HSIL: high-grade squamous intraepithelial lesion; LSIL: low-grade squamous intraepithelial lesion; SCC: squamous cell carcinoma; WNL: within
normal limits.
a Cytology analysed using ThinPrep PreservCyt medium (Hologic/Gen-Probe, Inc. San Diego, CA, USA).
b HR-HPV status determined using APTIMA HR-HPV mRNA Assay (Hologic/Gen-Probe, Inc.).
c The value for the variable ‘Husband’s migration status’ is missing survey data for eight women.
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represent the factors associated with HR-HPV infection in all of
Far-West Nepal. However, our study was conducted in Sanfebagar
Village Development Committee, which is 25 km from the district
capital of Mangalsen. The proximity of our health camp to the dis-
trict capital helped ensure that a diverse population of women had
access to the reproductive services we provided. Ninety eight
women registered for reproductive health services and completed
a survey but did not participate in screening, this could be for a
variety of possible reasons. Women continuously came to the
health camp throughout the day and women who registered
towards the end of the camp might not have received screening
services before the camp closed for the day. It is also possible
that the wait time to be screened was too long and women left
before completing the study. While several women completed a
survey but did not provide a biological sample we are confident
that the women who were not screened left the study at random
and did not inject bias into the study. The small sample size of
our study reduces the generalizability of our findings. While our
study sample consisted of 265 women, only 20 women tested
positive for HR-HPVand only 19 women had an abnormal cytology
result. The small number of women with outcomes in our study
restricted the number of covariates we could include in our multi-
variate models and could suggest that our study might be under-
powered. However, while our sample size is small, we were able
to include several covariates in our models that are considered to
beHR-HPV risk factors in other studies. It is possible somequestions
from our survey were misrepresented when translated into the
local dialect spoken in Achham. Given that the Nepali dialect
spoken in the district of Achham does not have a written form,
we had to rely on our interviewers to translate our survey into
the local Achham dialect when needed. Despite this, our survey
should not have suffered from difficulties in communication
because the majority of people living in Achham are able to
speak and understand Nepali and our interviewers were able to
speak the local Achham dialect.
Conclusions
Contrary to similar reports on HPV infection, there seems to be an
increasing prevalence of HR-HPV with age in our study popula-
tion. Our results could have potentially important implications
for reproductive health in Nepal. If older women are more likely
to test positive for HR-HPV than younger women, cervical screen-
ing resources could be saved by shifting more attention to this
population. Additionally, given that having a husband who has
migrated for work is not associated with HR-HPVor cervical abnor-
malities, reproductive health resources can be saved by shifting
cervical screening interventions away from this population. While
our study has potential implications for reproductive health in
Nepal, caution must be taken when assessing our results due to
our study’s small sample size. Future studies in a larger population
are warranted to validate our findings and assess whether our
observations are generalizable to spouses of migrant workers
from other parts of Nepal.
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